FDA New, GMP Do
Clinical Phase II, III Intermediates
GMP Custom synthesis, Full Document
R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
Email: info@eosmedchem.com; eosmedchem@gmail.com
This is my R&D youtube: https://youtu.be/r5cJdXKNXHk
| APX-115, 1395946-75-4 ;1270084-92-8 (free), APX-115 Intermediate 24317-96-2, stock 347.4g, white powder, assay by HPLC 99.5%, HNMR, LCMS we supply. |
| APX-115, 1395946-75-4 ;1270084-92-8 (free), APX-115 Intermediate 4930-98-7, stock 811.9g, white powder, assay by HPLC 98.1%, HNMR, LCMS we supply. |
| APX-115, 1395946-75-4 ;1270084-92-8 (free), APX-115 Intermediate 1270084-92-8, stock 952.5g, white powder, assay by HPLC 99.9%, HNMR, LCMS we supply. |
